Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 4;6(2):48.
doi: 10.3390/diseases6020048.

Treatment of Major Depressive Disorder in Pediatric Populations

Drew R Neavin  1 , Jeremiah Joyce  2 , Cosima Swintak  3
Affiliations
Review

Treatment of Major Depressive Disorder in Pediatric Populations

Drew R Neavin et al. Diseases. .

Abstract

Major depressive disorder (MDD) is a severe illness that afflicts about 16.6% of people over their lifetime. MDD is highly correlated with suicidality, and often first presents in adolescence. Unfortunately, many pediatric patients suffering from MDD go undiagnosed, and current evidence-based treatment options in the U.S. are limited to psychotherapy and two selective serotonin reuptake inhibitors approved by the United States Food and Drug Administration. Molecular mechanisms have been shown to play a role in MDD pathogenesis, progression, and response to medication, yet few studies have explored the role of these pathways in pediatric MDD. In this review, we outline the gravity and importance of MDD in pediatric patients, some challenges in diagnosis and treatment, current treatments available for pediatric patients, and research to investigate differences between pediatric and adult MDD. We hope that this review will provide an outline of the current understanding and treatment of MDD in pediatric patients, and provide thoughtful insights for future work that could advance our understanding of MDD in pediatric populations, and also identify new therapeutic strategies.

Keywords: major depressive disorder; pediatrics; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization, Depression. [(accessed on 29 April 2018)]; Available online: http://www.who.int/mediacentre/factsheets/fs369/en/
    1. Williams J.M., Barnhofer T., Crane C., Duggan D.S., Shah D., Brennan K., Krusche A., Crane R., Eames C., Jones M., et al. Pre-adult onset and patterns of suicidality in patients with a history of recurrent depression. J. Affect. Disord. 2012;138:173–179. doi: 10.1016/j.jad.2011.12.011. - DOI - PMC - PubMed
    1. Zisook S., Lesser I., Stewart J.W., Wisniewski S.R., Balasubramani G.K., Fava M., Gilmer W.S., Dresselhaus T.R., Thase M.E., Nierenberg A.A., et al. Effect of age at onset on the course of major depressive disorder. Am. J. Psychiatry. 2007;164:1539–1546. doi: 10.1176/appi.ajp.2007.06101757. - DOI - PubMed
    1. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 2005;62:593–602. doi: 10.1001/archpsyc.62.6.593. - DOI - PubMed
    1. Costello E.J., Mustillo S., Erkanli A., Keeler G., Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry. 2003;60:837–844. doi: 10.1001/archpsyc.60.8.837. - DOI - PubMed

LinkOut - more resources